Aditxt’s Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at ...
Researchers at UTHealth Houston are transforming skin cells into miniature brains to study schizophrenia and other mental ...
Money Talks News on MSN
Scientist Claims Humans Could Live 20,000 Years With New Technology
British scientist says humans could live 20,000 years through DNA reprogramming and cellular repair technology that ...
The Boston biotech founded by Harvard professor David Sinclair is testing whether cellular reprogramming can turn back the ...
Metabolic reprogramming in fibrotic lung diseases involves key metabolites like lactate, succinate, and 2-hydroxyglutarate, ...
GITEX GLOBAL 2025 concluded its 45th edition following a remarkable surge of deal-making and breakthrough unveilings spanning ...
Anti-aging biotech NewLimit plans to push a liver-rejuvenating mRNA medicine into the clinic with the aid of a $130 million series B fundraising round. The round was led by Kleiner Perkins alongside ...
Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- Aditxt, Inc. (NASDAQ: ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”, or the “Company”), a social innovation platform accelerating promising health innovations, today announced an update on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback